SVLSF VI, LLC → AVROBIO, Inc. TECX

Stake: — Shares: —

Composite Decision Signal · PASS (LOW BASE-RATE EDGE) Conviction Score: 16/100

Passive Schedule 13G filer baseline
Elevated short days-to-cover (10.6 DTC)

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

2 transactions

0 buys · 1 sales · 1 awards/exercises

Issuer Cluster

6 13D/G filings on this issuer

5 other filings besides this one

Filer Track Record

2 filings by this filer

1 other filing in the data moat

Short Interest · settle 2026-10-15

DTC 10.58

2,224,634 shares short · +0.1% vs prior

Form 4 Insider Transactions · last 365d

Date	Insider	Role	Type	Shares	Price	Value
2026-08-12	McNamara Peter	officer	Option exercise	43	$14.71	$633
2026-08-12	McNamara Peter	officer	Sale	43	$35.00	$2K

Other 13D/G Filings on AVROBIO, Inc.

Filed	Form	Filer	Stake	Shares
2025-02-10	SCHEDULE	SPRINGER TIMOTHY A	29.20%	4,226,058	view →
2025-02-07	SCHEDULE	Vida Ventures II, LLC	5.60%	1,028,674	view →
2025-02-07	SCHEDULE	MCGUIRE TERRANCE	6.30%	1,157,977	view →
2019-08-06	SC	Clarus Lifesciences III, L.P.	—	—	view →
2019-01-11	SC	Clarus Lifesciences III, L.P.	—	—	view →

Other Filings by SVLSF VI, LLC

Filed	Form	Issuer	Stake	Shares
2019-01-02	SC	Deciphera Pharmaceuticals, Inc.	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Free $0 (48h-delayed alerts) · Individual $49/mo (real-time) · Team & API $199/mo · Enterprise.

See pricing →